Ventana Medical Systems,a member of the Roche Group, and pharmaceutical company Boehringer Ingelheim (BI) have entered into a collaboration agreement for the development of companion diagnostic tests for BI oncology programs. Companion ...
SeaChange Pharmaceuticals has introduced its similarity ensemble approach (SEA) software called SEAware for predictive matching of drugs with disease and toxicity targets. SEAware provides analysis and visualization tools for prediction ...
Ensemble Therapeutics has entered into two-part research and development collaboration with Novartis for oral, macrocyclic inflammatory cytokine IL-17 antagonists and additional disease targets. The collaboration will leverage Ensemble's ...
Tags: Ensemble Therapeutics, Novartis
Daiichi Sankyo Company has decided to expand its collaborative drug discovery program with universities and research institutions based in Japan, Take a New challenge for Drug diScovery (TaNeDS) Global Program, to Germany, Switzerland and ...
Tags: Daiichi Sankyo, Medicine
Norwegian cardiovascular biopharma Serodus has signed a merger agreement with Danish peptide specialist Phlogo to expand cardiovascular drug candidate portfolio. Subject to approval by an EGM, the merger is expected to accelerate Serodus' ...
The US Patent and Trademark Office (USPTO) has granted a patent to GenSpera for the activation of peptide prodrugs by HK2, which is an enzyme secreted by prostate cancer cells. Composition of a series of prodrugs activated by HK2 enzyme ...
Tags: Peptide Prodrugs, Medicine
Pfizer has collaborated with the University of California, San Francisco (UCSF) to expand its centers for therapeutic innovation (CTI) into the development of small-molecule drug candidates and enhance its drug discovery capabilities. ...
Mercodia, a developer of immunoassays, has entered into a collaboration agreement with Profil Institute for Clinical Research. Under the alliance, Mercodia will offer its enzyme-linked immnosorbent assays (ELISA) as a component for Profil ...
Tags: Profil Institute, Mercodia, Clinical
Synta Pharmaceuticals, a US-based biopharmaceutical company, has named Dr Sumant Ramachandra as the new president of research and development (R&D). Dr Ramachandra served as senior vice president, R&D, regulatory and medical affairs, and ...
Tags: Synta Pharma, biopharmaceutical company, biopharmaceutical
The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to Arrowhead Research's patent application NO.13/336,028 covering dynamic polyconjugate (DPC) siRNA delivery system. The patent entitled, 'In Vivo ...
Tags: Arrowhead, NOA, therapeutic area targets
Domain Therapeutics SA announced today that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting ...
Tags: Domain Therapeutics SA, chemical, drugs
Sanford-Burnham Medical Research Institute and Florida Hospital have revamped obesity research partnership with Takeda Pharmaceutical Company for the discovery of novel anti-obesity therapeutics. The extended collaboration leverages new ...
Tags: Sanford-Burnham, Florida Hospital, obesity research, Takeda
NanoSmart Pharmaceuticals and University of California Los Angeles (UCLA) have signed a research alliance to advance the development of the drug delivery platform that uses human autoimmune antibodies targeting several tumor types. ...
Bicycle Therapeutics,had secured a tranched equity financing of £3.75 million to invest in selection of drug candidates using its bicyclic peptide technology platform. Current investors, Atlas Venture, Novartis Venture Fund, SR One ...
Tags: Bicycle, drug discovery funding, pharma, healthcare
Atlantic Pharmaceuticals has received two new US Patent and Trademark Office (USPTO) patents for its tamper-resistant SMART/Script drug delivery platform. The patents cover company's tamper-resistant platforms, designed to resist dose ...
Tags: Atlantic Pharmaceuticals, US Patent, drug delivery platform, healthcare